Synthesis and structure evaluation of a novel cantharimide and its cytotoxicity on SK-Hep-1 hepatoma cells

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 5, 2007, Pages 1155-1159

  Kok, Stanton Hon Lung ^a,b   Chui, Chung Hin ^a,b,c   Lam, Wing Sze ^a,b   Chen, Jien ^a,b   Lau, Fung Yi ^c   Wong, Raymond Siu Ming ^c   Cheng, Gregory Yin Ming ^c   Lai, Paul Bo San ^c   Leung, Thomas Wai Tong ^d   Yu, Michael Wing Yiu ^a,b   Tang, Johnny Cheuk On ^a,b   Chan, Albert Sun Chi ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

2 Aminobenzothiazole; Cantharimide; Neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; CANTHARIMIDE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HEMATOLOGIC DISEASE; HEPATOMA CELL; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CANTHARIDIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTRONS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846994393     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.039     Document Type: Article

References (27)

1. Wang G.S. J. Ethnopharmacol. 26 (1989) 147
2. Tagwireyi D., Ball D.E., Loga P.J., and Moyo S. Toxicon 38 (2000) 1865
3. Chen Y., Chen J., Yin S., Wang G., Tsauer W., Hsu S., and Hsu S. Int. J. Cancer 100 (2002) 158
4. Wu L., Chung J.G., Chen J.C., and Tsauer W. Am. J. Chin. Med. 29 (2001) 161
5. Hong C., Huang S.C., Lin S., Lee J.J., Chueh L., Lee C.K., Lin J., and Hsiao M. Biochem. Biophys. Res. Commun. 276 (2000) 278
6. Sun Z.X., Ma Q.W., Zhao T.D., Wei Y.L., Wang G.S., and Li J.S. World J. Gastroenterol. 6 (2000) 263
7. Tsauer W., Lin J., Lin P., Hsu F., and Chiang H. Anticancer Res. 17 (1997) 2095
8. Yang E., Tang W., Zhang K., Cheng L., and Mack P.O.P. Cancer Lett. 117 (1997) 93
9. Yi S., Wass J., Vincent P., and Iland H. Leuk. Res. 15 (1991) 883
10. Hutchinson I., Bradshaw T.D., Matthews C.S., Stevens M.F.G., and Westwell A.D. Bioorg. Med. Chem. Lett. 13 (2003) 471
11. Hutchinson I., Jennings S.A., Vishnuvajjala B.R., Westwell A.D., and Stevens M.F.G. J. Med. Chem. 45 (2002) 744
12. Lin P.-Y., Shi S.-J., Shu H.-L., Chen H.-F., Lin C.-C., Liu P.-C., and Wang L.-F. Bioorg. Chem. 28 (2000) 266
13. Hall I. Arch. Pharm. (Weinheim) 332 (1999) 115
14. Beneteau V., Besson T., Guillard J., Leonce S., and Pfeiffer B. Eur. J. Med. Chem. 34 (1999) 1053
15. Bradshaw T.D., Wrigley S., Shi D.-F., Schultz R.J., Paull K.D., and Stevens M.F.G. Br. J. Cancer 77 (1998) 745
16. Jimonet P., Audiau F., Barreau M., Blanchard J.-C., Boireau A., Bour Y., Coléno M.-A., Doble A., Doerflinger G., Do Huu C., Donat M.-H., Duchesne J.M., Ganil P., Guérémy C., Honoré E., Just B., Kerphirique R., Gontier S., Hubert P., Laduron P.M., Le Blevec J., Meunier M., Miquet J.-M., Nemecek C., Pasquet M., Piot O., Pratt J., Rataud J., Reibaud M., Stutzmann J.-M., and Mignani S. J. Med. Chem. 42 (1999) 2828
17. Benavides J., Camelin J.C., Mitrani N., Flamand F., Uzan A., Legrand J.J., Guérémy C., and Le Fur G. Neuropharmacology 24 (1985) 1085
18. Mizoule J., Meldrum B., Mazadier M., Croucher M., Ollat C., Uzan A., Legrand J.-J., Gueremy C., and Le Fur G. Neuropharmacology 24 (1985) 767
19. Tanaka T., Umekawa H., Saitoh M., Ishikawa T., Shin T., Ito M., Itoh H., Kawamatsu Y., Sugihara H., and Hidaka H. Mol. Pharmacol. 29 (1986) 264
20. Malgouris C., Bardot F., Daniel M., Pellis F., Rataud J., Uzan A., Blanchard J.-C., and Laduron P.M. J. Neurosci. 9 (1989) 3720
21. Pratt J., Rataud J., Bardot F., Roux M., Blanchard J.-C., Laduron P.M., and Stutzmann J.-M. Neurosci. Lett. 140 (1992) 225
22. Quiroga J., Hernández P., Insuasty B., Aboni{dotless}́a R., Cobo J., Sánchez A., Nogueras M., and Low J.N. J. Chem. Soc., Perkin Trans. 1 555 (2002) and references cited therein
23. Kok S.H.L., Chui C.H., Lam W.S., Chen J., Tang J.C.O., Lau F.Y., Cheng G.Y.M., Wong R.S.M., and Chan A.S.C. Int. J. Mol. Med. 17 (2006) 945
24. Kok S.H.L., Chui C.H., Lam W.S., Chen J., Tang J.C.O., Lau F.Y., Cheng G.Y.M., Wong R.S.M., and Chan A.S.C. Int. J. Mol. Med. 17 (2006) 151
25. Ismail I.A., Sharp D.E., and Chedekel M.R. J. Org. Chem. 45 (1980) 2243
26. Yang N.-S., Shyur L.-F., Chen C.-H., Wang S.-Y., and Tzeng C.-M. J. Biomed. Sci. 11 (2004) 418
27. 4cells were treated under the same conditions as mentioned above. After fixation and permeabilization treatment, intracellular DNA fragments were labeled with FITC and analyzed with the excitation wavelength of 485 nm and emission wavelength of 515 nm.